The relationship between the presence of HPV infection and biofilm formation in cervicovaginal smears.
Biofilm
Cervicovaginal smear
HPV
Vaginal microbiota
Journal
Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
13
04
2020
accepted:
30
06
2020
pubmed:
6
7
2020
medline:
30
4
2021
entrez:
6
7
2020
Statut:
ppublish
Résumé
To demonstrate and understand the association of HPV infection and biofilm formation. The study consisted of cervicovaginal samples of 72 women who were evaluated at the colposcopy unit. Papanicolaou staining was used for cytological examination while "Crystal Violet Binding" assay was performed to detect biofilm formation. HPV-DNA was positive in 55.5% (n = 40) of the patients. The biofilm formation rate was statistically significantly higher in the HPV-positive women (45%) compared to HPV-negative women (21.9%) (P < 0.05). There was a statistically significant relationship between the presence of single HPV and "high-risk HPV" types and biofilm formation (P < 0.05). Biofilm formation was found in 80% of women with abnormal smear demonstrating atypical epithelial cells (P < 0.05). Biofilm formation is more frequent at the cervicovaginal microbiota of patients with HPV infection. This finding is especially important in cases with atypical epithelial cells at their cervicovaginal smears.
Identifiants
pubmed: 32623704
doi: 10.1007/s15010-020-01478-5
pii: 10.1007/s15010-020-01478-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
735-740Références
Gheit T. Mucosal and cutaneous human papillomavirus infections and cancer biology. Front Oncol. 2019;9:355.
pubmed: 31134154
pmcid: 6517478
Hufbauer M, Maltseva M, Meinrath J, Lechner A, Beutner D, Huebbers CU, et al. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer. Int J Cancer. 2018;143:1426–39.
pubmed: 29663357
Hufbauer M, Akgül B. Molecular mechanisms of human papillomavirus induced skin carcinogenesis. Viruses. 2017;9:187.
pmcid: 5537679
Georgescu SR, Mitran CI, Mitran MI, Caruntu C, Sarbu MI, Matei C, et al. New insights in the pathogenesis of HPV infection and the associated carcinogenic processes: the role of chronic inflammation and oxidative stress. J Immunol Res. 2018;2018:5315816.
pubmed: 30225270
pmcid: 30225270
Giuliano AR, Sedjo RL, Roe DJ, Harris R, Baldwin S, Papenfuss MR, et al. Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control. 2002;13:839–46.
pubmed: 12462549
Norenhag J, Du J, Olovsson M, Verstraelen H, Engstrand L, Brusselaers N. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG. 2020;127:171–80.
pubmed: 31237400
De Araujo Souza PS, Villa LL. Genetic susceptibility to infection with human papillomavirus and development of cervical cancer in women in Brazil. Mutat Res. 2003;544:375–83.
pubmed: 14644340
Doerflinger SY, Throop AL, Herbst-Kralovetz MM. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J Infect Dis. 2014;209:1989–99.
pubmed: 24403560
Torcia MG. Interplay among vaginal microbiome, immune response and sexually transmitted viral infections. Int J Mol Sci. 2019;20:266.
pmcid: 6359169
Zárate G, Nader-Macias ME. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett Appl Microbiol. 2006;43:174–80.
pubmed: 16869901
López D, Vlamakis H, Kolter R. Biofilms. Cold Spring Harb Perspect Biol. 2010;2:a000398.
pubmed: 20519345
pmcid: 2890205
Gebreyohannes G, Nyerere A, Bii C, Sbhatu DB. Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms. Heliyon. 2019;5:e02192.
pubmed: 31463386
pmcid: 6709409
Cavalcanti ÉFF, Silva CR, Ferreira DC, Ferreira MVM, Vanderborght PR, Torres MCMB, et al. Detection of human papillomavirus in dental biofilm and the uterine cervix of a pregnant adolescent. Sao Paulo Med J. 2016;134:88–91.
pubmed: 25885485
Lee JE, Lee S, Lee H, Song YM, Lee K, Han MJ, et al. Association of the vaginal microbiota with human papillomavirus infection in a Korean Twin Cohort. PLoS ONE. 2013;8:e63514.
pubmed: 23717441
pmcid: 3661536
Audirac-Chalifour A, Torres-Poveda K, Bahena-Román M, Téllez-Sosa J, Martínez-Barnetche J, Cortina-Ceballos B, et al. Cervical microbiome and cytokine profile at various stages of cervical cancer: a pilot study. PLoS ONE. 2016;11:e0153274.
pubmed: 27115350
pmcid: 4846060
Di Paola M, Sani C, Maria Clemente A, Iossa A, Perissi E, Castronovo G, et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection. Sci Rep. 2017;7:10200.
pubmed: 28860468
pmcid: 5579045
Brotman RM, Shardell MD, Gajer P, Tracy JK, Zenilman JM, Ravel J, et al. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J Infect Dis. 2014;210:1723–33.
pubmed: 24943724
pmcid: 4296189
Sahal G, Bilkay IS. Distribution of clinical isolates of Candida spp. and antifungal susceptibility of high biofilm-forming Candida isolates. Rev Soc Bras Med Trop. 2018;51:644–50.
pubmed: 30304271
Liang Y, Chen M, Qin L, Wan B, Wang H. A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia. Infect Agent Cancer. 2019;14:29.
pubmed: 31673281
pmcid: 6815368
Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: What do we know and where are we going next? Microbiome. 2016;4:58.
pubmed: 27802830
pmcid: 5088670
Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol. 2015;6:81.
pubmed: 25859220
pmcid: 4373506
Leyva-Gómez G, Del Prado-Audelo ML, Ortega-Peña S, Mendoza-Muñoz N, Urbán-Morlán Z, González-Torres M, et al. Modifications in vaginal microbiota and their influence on drug release: challenges and opportunities. Pharmaceutics. 2019;11:E217.
pubmed: 31064154
Zahran KM, Agban MN, Ahmed SH, Hassan EA, Sabet MA. Patterns of candida biofilm on intrauterine devices. J Med Microbiol. 2015;64:375–81.
pubmed: 25681320
Auler ME, Morreira D, Rodrigues FFO, Abrão MS, Margarido PFR, Matsumoto FE, et al. Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis biofilm formation on IUDs in patients with vulvovaginal candidiasis. Med Mycol. 2010;48:211–6.
pubmed: 20055746
Jung HS, Ehlers MM, Lombaard H, Redelinghuys MJ, Kock MM. Etiology of bacterial vaginosis and polymicrobial biofilm formation. Crit Rev Microbiol. 2017;43:651–67.
pubmed: 28358585
Rieth KKS, Gill SR, Lott-Limbach AA, Merkley MA, Botero N, Allen PD, et al. Prevalence of High-risk human papillomavirus in tonsil tissue in healthy adults and colocalization in biofilm of tonsillar crypts. JAMA Otolaryngol Head Neck Surg. 2018;144:231–7.
pubmed: 29372248
pmcid: 5885877
Zhou Y, Wang L, Pei F, Ji M, Zhang F, Sun Y, et al. Patients with LR-HPV infection have a distinct vaginal microbiota in comparison with healthy controls. Front Cell Infect Microbiol. 2019;9:294.
pubmed: 31555603
pmcid: 6722871
Kyrgiou M, Mitra A, Moscicki AB. Does the vaginal microbiota play a role in the development of cervical cancer? Transl Res. 2017;179:168–82.
pubmed: 27477083
Safaeian M, Solomon D, Castle PE. Cervical cancer prevention-cervical screening: science in evolution. Obstet Gynecol Clin N Am. 2007;34:739–60 (ix).
Barut MU, Kale A, Kuyumcuoğlu U, Bozkurt M, Ağaçayak E, Özekinci S, et al. Analysis of sensitivity, specificity, and positive and negative predictive values of smear and colposcopy in diagnosis of premalignant and malignant cervical lesions. Med Sci Monit. 2015;21:3860–7.
pubmed: 26655816
pmcid: 4678924
Tuncer S, Başaran M, Ustaçelebi Ş, Mocan-Kuzey G. High-risk Human Papilloma Virus (HPV) infection determined by Hybrid Capture II Assay in a Turkish university hospital outpatient clinic. Gynecol Obstet Reprod Med. 2006;12:129–34.